Skip to main
CVSA

CVSA Stock Forecast & Price Target

CVSA Analyst Ratings

Based on 2 analyst ratings
Buy
Strong Buy 50%
Buy 50%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Covista is projected to have continued success in the healthcare education sector due to its personalized and tech-enabled approach, supported by a growing community of alumni. The company's enrollment growth, strong revenue numbers, and potential for increased margins make it an attractive investment opportunity. With its long-term targets and expansion plans, analysts anticipate Covista's stock to rebound, making it a recommended Buy for investors.

Bears say

Covista is facing several challenges that could impact its stock performance in the near future, including potential regulatory challenges, missed long-term targets, potential liabilities from DeVry, and potential investor rotation away from the healthcare sector. Additionally, Covista's reliance on traditional on-ground coursework may serve as a barrier to competing against rapidly growing non-profit players in the online education space. Furthermore, while Covista's acquisition of Walden University and planned expansion of Chamberlain University may drive margin expansion, it remains to be seen if it can counteract potential enrollment declines and sustain long-term growth.

CVSA has been analyzed by 2 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 50% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Adtalem Global Education Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Adtalem Global Education Inc (CVSA) Forecast

Analysts have given CVSA a Buy based on their latest research and market trends.

According to 2 analysts, CVSA has a Buy consensus rating as of Aug 5, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $155, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $155, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Adtalem Global Education Inc (CVSA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.